Tag: #Active Pharmaceutical Ingredients (API)

Chinese firms accelerate production of hydroxychloroquine

Ma Jingjing and Yin Yeping April 13, 2020

Chinese firms accelerate production of hydroxychloroquine

Active pharmaceutical ingredient (API) manufacturers in China are going full speed ahead to produce what US President Donald Trump has called a "game-changer" as well as other APIs to help countries around the world combat the COVID-19 pandemic, as India moves to partially resume exports of two crucial...More

US may face drug supply gap as China’s API companies disrupted amid epidemic

Yin Yeping and Zhang Hongpei March 10, 2020

US may face drug supply gap as China’s API companies disrupted amid epidemic

China' s annual exports of $100 billion worth of active pharmaceutical ingredients (API) to the US are encountering disruptions as the coronavirus assault continues, industry insiders said. The US Food and Drug Administration (FDA) issued a statement on Thursday, saying "a (US) manufacturer has alerted us to a...More